Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy Comparison of Tisagenlecleucel Versus Standard of Care in Patients with Relapsed or Refractory Follicular Lymphoma
Efficacy Comparison of Tisagenlecleucel Versus Standard of Care in Patients with Relapsed or Refractory Follicular Lymphoma
2021
Gilles Salles
Stephen J. Schuster
Martin Dreyling
Luca Fischer
John Kuruvilla
Piers Em. Patten
Bastian von Tresckow
Sonali M. Smith
Ana Isabel Jiminez Ubieto
Keith L. Davis
Carla Anjos
Jufen Chu
Jie Zhang
C Lobetti Bodoni
Catherine Thieblemont
Nathan Fowler
Michael Dickinson
Joaquin Martinez-Lopez
Yucai Wang
Brian K. Link
Keywords:
standard of care
Oncology
Internal medicine
Refractory Follicular Lymphoma
in patient
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]
map